MLB: Mo Vaughn admits using human growth hormone

Date:

Share post:


Former American League MVP Mo Vaughn admitted using human growth hormone later in his career.

The three-time All-Star told The Athletic he had HGH injected into his troublesome knee in order to continue playing.

“I was trying to do everything I could,” Vaughn said. “I knew I had a bad, degenerative knee. I was shooting HGH in my knee. Whatever I could do to help the process.”

Vaughn, now 56, rose to stardom as a slugging first baseman with the Boston Red Sox from 1991-98. He made three All-Star teams and was named the 1995 AL MVP after batting .300 with 39 homers and 126 RBIs.

Vaughn spent two seasons with the Anaheim Angels from 1999-2000 before missing the 2001 season with a ruptured biceps tendon. He finished out his career with a two-year stint with the New York Mets from 2002-03.

Major League Baseball did not ban HGH until 2005. In 2007, Vaughn was named in the Mitchell report that looked into the use of performance-enhancing drugs and steroids in baseball.

Vaughn batted .293 with 328 home runs and 1,064 RBIs in 1,512 career games. He appeared on the Hall of Fame ballot in 2009 but received only six votes, or just 1.1 percent.

–Field Level Media

spot_img

Related articles

NCAABBL: Michael Earley to be retained as Aggies’ head baseball coach

Texas A&M Director of Athletics Trev Alberts announced today that first-year head baseball coach Michael Earley would return...

MLB: Guardians activate DH David Fry from 60-day IL

The Cleveland Guardians activated designated hitter David Fry from the 60-day injured list and added him to the...

MLB: Twins reinstate OF Matt Wallner from injured list

The Minnesota Twins reinstated outfielder Matt Wallner from the 10-day injured list on Saturday. Wallner, out since mid-April with...

MLB: Astros DH Yordan Alvarez dealing with fracture in hand

Houston Astros designated Yordan Alvarez has a "very small fracture" in his right hand that is 60 percent...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.